Patents by Inventor David ARNLUND

David ARNLUND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230296602
    Abstract: Antibodies against a virus can be detected in a sample using at least one reagent comprising at least one capture molecule immobilized to a particle, which reagent in the presence of such antibodies forms an anti-virus antibody-capture molecule complex, wherein the presence of said complex is qualitatively, quantitatively or semi-quantitatively determined by measuring a signal generated by said complex, said particle is a nanoparticle and said capture molecule is immobilized to said nanoparticle simultaneously with a co-molecule which is smaller than said capture molecule. When the capture molecule is a virus epitope, the co-molecule preferably has a molecular weight in the range of 50-1500 Da, wherein said co-molecules when immobilized on said nanoparticle separate the capture molecules so that an average distance between two adjacent capture molecules is greater than a distance between the antigen binding sites of the anti-virus antibody to be detected.
    Type: Application
    Filed: May 20, 2021
    Publication date: September 21, 2023
    Inventors: David ARNLUND, Camilla FANT, Aleksandra Mandic HAVELKA, Clara Mathilde HIDDEN, Torsten KNÜTTEL, Evelina LE COMTE, Tom NILSEN, Erling SUNDREHAGEN